Form 8-K - Current report:
SEC Accession No. 0000950170-21-003784
Filing Date
2021-11-09
Accepted
2021-11-09 16:49:29
Documents
14
Period of Report
2021-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tern-20211109.htm   iXBRL 8-K 54014
2 EX-99.1 tern-ex99_1.htm EX-99.1 47971
3 GRAPHIC img52906712_0.jpg GRAPHIC 4542
  Complete submission text file 0000950170-21-003784.txt   241396

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20211109.xsd EX-101.SCH 2496
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20211109_pre.xml EX-101.PRE 10683
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20211109_lab.xml EX-101.LAB 14564
7 EXTRACTED XBRL INSTANCE DOCUMENT tern-20211109_htm.xml XML 5117
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 211392957
SIC: 2834 Pharmaceutical Preparations